Search Results - "Berntorp, E."

If you know you will also see: population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia by Berntorp, E.

Get full text

Replacement therapy during surgery in von Willebrand disease needs personalization by Berntorp, E.

Get full text

Haemophilia treatment in 2030 by Berntorp, E.

“…Introduction Looking into the future is difficult and sometimes hazardous. A reliable look into haemophilia treatment in 2030 should be based on history and…”
Get full text

Defining extended half‐life rFVIII—A critical review of the evidence by Mahlangu, J., Young, G., Hermans, C., Blanchette, V., Berntorp, E., Santagostino, E.

“…Introduction Recent haemophilia treatment advances include new recombinant FVIII (rFVIII) products with improved pharmacokinetic (PK) properties that aim to…”
Get full text

Future of haemophilia outcome assessment: registries are key to optimized treatment by Berntorp, E.

“…Content List – Read more articles from the symposium: Future of haemophilia outcome assessment…”
Get full text

Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors by BERNTORP, E.

“…The bypassing agents factor eight inhibitor bypassing activity (FEIBA) anti‐inhibitor coagulant complex and recombinant activated factor VII (rFVIIa) have been…”
Get full text

Immune tolerance induction: What have we learned over time? by Brackmann, H.‐H., White, G.C., Berntorp, E., Andersen, T., Escuriola‐Ettingshausen, C.

“…Development of inhibitory antibodies to infused factor VIII (FVIII) concentrates continues to be the most serious complication of haemophilia A management…”
Get full text

Registry‐based outcome assessment in haemophilia: a scoping study to explore the available evidence by Osooli, M., Berntorp, E.

“…Haemophilia is a congenital disorder with bleeding episodes as its primary symptom. These episodes can result in negative outcomes including joint damage, loss…”
Get full text

Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens by BERNTORP, E.

“…In patients with severe haemophilia, spontaneous bleeding into joints initiates a sequence of events culminating in disabling arthropathy. Early evidence from…”
Get full text

Inhibitors in haemophilia: what have we learned from registries? A systematic review by Osooli, M., Berntorp, E.

“…Congenital haemophilia A and B are genetic disorders affecting factor VIII and factor IX production, respectively. Factor replacement is the only effective…”
Get full text

Preference‐based valuation of treatment attributes in haemophilia A using web survey by Steen Carlsson, K., Andersson, E., Berntorp, E.

“…Introduction Clinical trials have shown promising results for extended half‐life factor VIII concentrates but little is known about individuals' valuation of…”
Get full text

Pharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study by Berntorp, E.

“…Summary The concept of using pharmacokinetics for prophylactic dose tailoring with limited blood sampling in clinical practice has been demonstrated for factor…”
Get full text

Treatment and prevention of acute bleedings in von Willebrand disease - efficacy and safety of Wilate®, a new generation von Willebrand factor/factor VIII concentrate by BERNTORP, E., WINDYGA, J.

“…For many patients with von Willebrand disease (VWD), the replacement therapy with von Willebrand factor (VWF)/factor VIII (FVIII) concentrates is the treatment…”
Get full text

Bleeding‐related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network by Holm, E., Carlsson, K. Steen, Lövdahl, S., Lail, A. E., Abshire, T. C., Berntorp, E.

“…Introduction Patients suffering from von Willebrand disease (VWD) have a variety of bleeding symptoms and require both outpatient care for treatment and, in…”
Get full text

History of prophylaxis by Berntorp, E.

Get full text

Population pharmacokinetics of plasma‐derived factor IX: procedures for dose individualization by Brekkan, A., Berntorp, E., Jensen, K., Nielsen, E. I., Jönsson, S.

“…Essentials A population pharmacokinetic model and sparse factor IX (FIX) levels may be used in dose individualization. FIX sampling schedules for dose…”
Get full text

Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis by Valentino, L. A., Pipe, S. W., Collins, P. W., Blanchette, V. S., Berntorp, E., Fischer, K., Ewenstein, B. M., Oh, M., Spotts, G.

“…Introduction We previously showed that pharmacokinetic‐guided prophylaxis (PKP) allows the dosing interval to be extended while maintaining a specific trough…”
Get full text

Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network by Abshire, T., Cox‐Gill, J., Kempton, C. L., Leebeek, F. W. G., Carcao, M., Kouides, P., Donfield, S., Berntorp, E.

“…Summary Background Treatment of mucosal bleeding (epistaxis, gastrointestinal bleeding, and menorrhagia) and joint bleeding remains problematic in clinically…”
Get full text

Low agreement between fresh and frozen‐thawed platelet‐rich plasma in the calibrated automated thrombogram assay by Ljungkvist, M., Lövdahl, S., Zetterberg, E., Berntorp, E.

“…Introduction Thrombin generation tests (TGTs) are considered to give more detailed information of the overall coagulation capability of a patient than…”
Get full text

Hypertension and cardiovascular diseases in Swedish persons with haemophilia — A longitudinal registry study by Lövdahl, Susanna, Henriksson, Karin M., Baghaei, Fariba, Holmström, Margareta, Berntorp, Erik, Astermark, Jan

“…Data on the prevalence of hypertension and cardiovascular diseases (CVD) among persons with haemophilia (PWH) vary. Sweden has a long tradition of maintaining…”
Get full text